Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-11-063209
Filing Date
2011-11-14
Accepted
2011-11-14 06:11:14
Documents
13
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 v240119_10q.htm 10-Q 629410
2 v240119_ex31-1.htm EX-31.1 10347
3 v240119_ex31-2.htm EX-31.2 10317
4 v240119_ex32.htm EX-32 6907
5 GRAPHIC sig.jpg GRAPHIC 15295
6 GRAPHIC sig2.jpg GRAPHIC 8095
7 GRAPHIC sig3.jpg GRAPHIC 9446
  Complete submission text file 0001144204-11-063209.txt   2441678

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ovit-20110930_pre.xml EX-101.PRE 77504
9 XBRL INSTANCE DOCUMENT ovit-20110930.xml EX-101.INS 320882
10 XBRL TAXONOMY EXTENSION SCHEMA ovit-20110930.xsd EX-101.SCH 12356
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ovit-20110930_cal.xml EX-101.CAL 41755
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ovit-20110930_def.xml EX-101.DEF 56915
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE ovit-20110930_lab.xml EX-101.LAB 130962
Mailing Address 14785 OMICRON DRIVE SUITE 104 SAN ANTONIO TX 78245
Business Address 14785 OMICRON DRIVE SUITE 104 SAN ANTONIO TX 78245 210 677 6000
ONCOVISTA INNOVATIVE THERAPIES, INC (Filer) CIK: 0001094847 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-28347 | Film No.: 111197327
SIC: 2834 Pharmaceutical Preparations